Immunoglobulin A N-glycosylation Presents Important Body Fluid-specific Variations in Lactating Mothers

Elisha Goonatilleke, Jennifer T. Smilowitz, Karina V. Mariño, Bruce J. German, Carlito B. Lebrilla, Mariana Barboza

Research output: Contribution to journalArticle

Abstract

Secretory Immunoglobulin A (SIgA) is central to mucosal immunity: represents one of the main immunological mechanisms of defense against the potential attack of pathogens. During lactation SIgA is produced by plasmablasts in the mammary gland and is present in breast milk, playing a vital role in the passive immunity of the newborn. Interestingly, the different components of SIgA are highly N-glycosylated, and these N-Glycans have an essential role in health maintenance. In this work, we performed a glycomic study to compare N-glycosylation of SIgA purified from mature breast milk and saliva, and plasma IgA from the same lactating participants. Our results revealed a greater diversity than previously reported, with 89 glycan compositions that may correspond to over 250 structures. Among these glycans, 54 glycan compositions were characterized as body-fluid specific. Most of these unique N-Glycan compositions identified in SIgA from mature milk and IgA from plasma were fucosylated and both fucosylated and sialylated species, whereas in salivary SIgA the unique structures were mainly undecorated complex N-Glycans. In addition, we evaluated the effect of delivery mode on (S)IgA glycosylation. Lactating participants who had given birth by vaginal delivery presented an increased proportion of high mannose and fucosylated glycans in salivary SIgA, and selected high mannose, fucosylated, sialylated, and both fucosylated and sialylated glycans in plasma IgA, indicating that the hormonal changes during vaginal delivery could affect plasma and saliva IgA. These results reveal the structural details that provide a new dimension to the roles of (S)IgA N-Glycans in different tissues, and especially in maternal and new-born protection and infant development. The design of optimal recombinant IgA molecules specifically targeted to protect mucosal surfaces will need to include this dimension of structural detail.

Original languageEnglish (US)
Pages (from-to)2165-2177
Number of pages13
JournalMolecular & cellular proteomics : MCP
Volume18
Issue number11
DOIs
StatePublished - Nov 1 2019

Fingerprint

Glycosylation
Body fluids
Body Fluids
Secretory Immunoglobulin A
Immunoglobulin A
Polysaccharides
Plasmas
Human Milk
Mannose
Saliva
Chemical analysis
Glycomics
Mucosal Immunity
Pathogens
Human Mammary Glands
Child Development
Lactation
Immunity
Milk
Mothers

Keywords

  • breast milk
  • chromatography
  • glycomics
  • immunoglobulin A
  • lactation
  • mass spectrometry
  • N-glycosylation
  • plasma or serum analysis
  • saliva

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology

Cite this

Immunoglobulin A N-glycosylation Presents Important Body Fluid-specific Variations in Lactating Mothers. / Goonatilleke, Elisha; Smilowitz, Jennifer T.; Mariño, Karina V.; German, Bruce J.; Lebrilla, Carlito B.; Barboza, Mariana.

In: Molecular & cellular proteomics : MCP, Vol. 18, No. 11, 01.11.2019, p. 2165-2177.

Research output: Contribution to journalArticle

Goonatilleke, Elisha ; Smilowitz, Jennifer T. ; Mariño, Karina V. ; German, Bruce J. ; Lebrilla, Carlito B. ; Barboza, Mariana. / Immunoglobulin A N-glycosylation Presents Important Body Fluid-specific Variations in Lactating Mothers. In: Molecular & cellular proteomics : MCP. 2019 ; Vol. 18, No. 11. pp. 2165-2177.
@article{fe53f90f24984927b960a5f0dd5a22ab,
title = "Immunoglobulin A N-glycosylation Presents Important Body Fluid-specific Variations in Lactating Mothers",
abstract = "Secretory Immunoglobulin A (SIgA) is central to mucosal immunity: represents one of the main immunological mechanisms of defense against the potential attack of pathogens. During lactation SIgA is produced by plasmablasts in the mammary gland and is present in breast milk, playing a vital role in the passive immunity of the newborn. Interestingly, the different components of SIgA are highly N-glycosylated, and these N-Glycans have an essential role in health maintenance. In this work, we performed a glycomic study to compare N-glycosylation of SIgA purified from mature breast milk and saliva, and plasma IgA from the same lactating participants. Our results revealed a greater diversity than previously reported, with 89 glycan compositions that may correspond to over 250 structures. Among these glycans, 54 glycan compositions were characterized as body-fluid specific. Most of these unique N-Glycan compositions identified in SIgA from mature milk and IgA from plasma were fucosylated and both fucosylated and sialylated species, whereas in salivary SIgA the unique structures were mainly undecorated complex N-Glycans. In addition, we evaluated the effect of delivery mode on (S)IgA glycosylation. Lactating participants who had given birth by vaginal delivery presented an increased proportion of high mannose and fucosylated glycans in salivary SIgA, and selected high mannose, fucosylated, sialylated, and both fucosylated and sialylated glycans in plasma IgA, indicating that the hormonal changes during vaginal delivery could affect plasma and saliva IgA. These results reveal the structural details that provide a new dimension to the roles of (S)IgA N-Glycans in different tissues, and especially in maternal and new-born protection and infant development. The design of optimal recombinant IgA molecules specifically targeted to protect mucosal surfaces will need to include this dimension of structural detail.",
keywords = "breast milk, chromatography, glycomics, immunoglobulin A, lactation, mass spectrometry, N-glycosylation, plasma or serum analysis, saliva",
author = "Elisha Goonatilleke and Smilowitz, {Jennifer T.} and Mari{\~n}o, {Karina V.} and German, {Bruce J.} and Lebrilla, {Carlito B.} and Mariana Barboza",
year = "2019",
month = "11",
day = "1",
doi = "10.1074/mcp.RA119.001648",
language = "English (US)",
volume = "18",
pages = "2165--2177",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - Immunoglobulin A N-glycosylation Presents Important Body Fluid-specific Variations in Lactating Mothers

AU - Goonatilleke, Elisha

AU - Smilowitz, Jennifer T.

AU - Mariño, Karina V.

AU - German, Bruce J.

AU - Lebrilla, Carlito B.

AU - Barboza, Mariana

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Secretory Immunoglobulin A (SIgA) is central to mucosal immunity: represents one of the main immunological mechanisms of defense against the potential attack of pathogens. During lactation SIgA is produced by plasmablasts in the mammary gland and is present in breast milk, playing a vital role in the passive immunity of the newborn. Interestingly, the different components of SIgA are highly N-glycosylated, and these N-Glycans have an essential role in health maintenance. In this work, we performed a glycomic study to compare N-glycosylation of SIgA purified from mature breast milk and saliva, and plasma IgA from the same lactating participants. Our results revealed a greater diversity than previously reported, with 89 glycan compositions that may correspond to over 250 structures. Among these glycans, 54 glycan compositions were characterized as body-fluid specific. Most of these unique N-Glycan compositions identified in SIgA from mature milk and IgA from plasma were fucosylated and both fucosylated and sialylated species, whereas in salivary SIgA the unique structures were mainly undecorated complex N-Glycans. In addition, we evaluated the effect of delivery mode on (S)IgA glycosylation. Lactating participants who had given birth by vaginal delivery presented an increased proportion of high mannose and fucosylated glycans in salivary SIgA, and selected high mannose, fucosylated, sialylated, and both fucosylated and sialylated glycans in plasma IgA, indicating that the hormonal changes during vaginal delivery could affect plasma and saliva IgA. These results reveal the structural details that provide a new dimension to the roles of (S)IgA N-Glycans in different tissues, and especially in maternal and new-born protection and infant development. The design of optimal recombinant IgA molecules specifically targeted to protect mucosal surfaces will need to include this dimension of structural detail.

AB - Secretory Immunoglobulin A (SIgA) is central to mucosal immunity: represents one of the main immunological mechanisms of defense against the potential attack of pathogens. During lactation SIgA is produced by plasmablasts in the mammary gland and is present in breast milk, playing a vital role in the passive immunity of the newborn. Interestingly, the different components of SIgA are highly N-glycosylated, and these N-Glycans have an essential role in health maintenance. In this work, we performed a glycomic study to compare N-glycosylation of SIgA purified from mature breast milk and saliva, and plasma IgA from the same lactating participants. Our results revealed a greater diversity than previously reported, with 89 glycan compositions that may correspond to over 250 structures. Among these glycans, 54 glycan compositions were characterized as body-fluid specific. Most of these unique N-Glycan compositions identified in SIgA from mature milk and IgA from plasma were fucosylated and both fucosylated and sialylated species, whereas in salivary SIgA the unique structures were mainly undecorated complex N-Glycans. In addition, we evaluated the effect of delivery mode on (S)IgA glycosylation. Lactating participants who had given birth by vaginal delivery presented an increased proportion of high mannose and fucosylated glycans in salivary SIgA, and selected high mannose, fucosylated, sialylated, and both fucosylated and sialylated glycans in plasma IgA, indicating that the hormonal changes during vaginal delivery could affect plasma and saliva IgA. These results reveal the structural details that provide a new dimension to the roles of (S)IgA N-Glycans in different tissues, and especially in maternal and new-born protection and infant development. The design of optimal recombinant IgA molecules specifically targeted to protect mucosal surfaces will need to include this dimension of structural detail.

KW - breast milk

KW - chromatography

KW - glycomics

KW - immunoglobulin A

KW - lactation

KW - mass spectrometry

KW - N-glycosylation

KW - plasma or serum analysis

KW - saliva

UR - http://www.scopus.com/inward/record.url?scp=85074445661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074445661&partnerID=8YFLogxK

U2 - 10.1074/mcp.RA119.001648

DO - 10.1074/mcp.RA119.001648

M3 - Article

C2 - 31409668

AN - SCOPUS:85074445661

VL - 18

SP - 2165

EP - 2177

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 11

ER -